Enhancement of gastrointestinal absorption of isoliquiritigenin by nanostructured lipid carrier

Advanced Powder Technology

Volumn 25, Issue 3, 2014, Pages 1060-1068

  Zhang, Xiaoyun ^a   Qiao, Hua ^a   Zhang, Taifeng ^b   Shi, Yanbin ^a   Ni, Jingman ^a  

^a LANZHOU UNIVERSITY   (China)

^b Cancer Hospital of Gansu Province   (China)

Author keywords

Gastrointestinal absorption in situ; Isoliquiritigenin; Nanostructured lipid carriers; Pharmacokinetics; Relative bioavailability

Indexed keywords

BIOCHEMISTRY; CONTROLLED DRUG DELIVERY; FLAVONOIDS; PHARMACOKINETICS; SOLS; TARGETED DRUG DELIVERY;

GASTROINTESTINAL ABSORPTIONS; ISOLIQUIRITIGENIN; NANOSTRUCTURED LIPID CARRIER (NLC); NANOSTRUCTURED LIPID CARRIERS; PHARMACOKINETIC STUDIES; PHARMACOLOGICAL EFFECTS; POORLY WATER-SOLUBLE DRUGS; RELATIVE BIOAVAILABILITY;

WATER ABSORPTION;

EID: 84901618947     PISSN: 09218831     EISSN: 15685527     Source Type: Journal    
DOI: 10.1016/j.apt.2014.02.012     Document Type: Article

References (54)

1. H. Haraguchi, H. Ishikawa, K. Mizutani, Y. Tamura, and T. Kinoshita Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata Bioorg. Med. Chem. 6 1998 339 347 (Pubitemid 28144484)
2. Y.W. Chin, H.A. Jung, Y. Liu, B.N. Su, J.A. Castoro, W.J. Keller, M.A. Pereira, and A.D. Kinghorn Anti-oxidant constituents of the roots and stolons of licorice (Glycyrrhiza glabra) J. Agric. Food Chem. 55 2007 4691 4697 (Pubitemid 46960894)
3. C.K. Lee, S.H. Son, K.K. Park, J.H. Park, S.S. Lim, and W.Y. Chung Isoliquiritigenin inhibits tumor growth and protects the kidney and liver against chemotherapyinduced toxicity in a mouse xenograft model of colon carcinoma J. Pharmacol. Sci. 106 2008 444 451 (Pubitemid 351468597)
4. S. Kumar, A. Sharma, B. Madan, V. Singhal, and B. Ghosh Isoliquiritigenin inhibits Ikappa B kinase activity and ROS generation to block TNF-Alpha induced expression of cell adhesion molecules on human endothelial cells Biochem. Pharmacol. 73 2007 1602 1612 (Pubitemid 46533973)
5. J.Y. Kim, S.J. Park, K.J. Yun, Y.W. Cho, H.J. Park, and K.T. Lee Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kB in Raw264.7 macrophages Eur. J. Pharmacol. 584 2008 175 184
6. T. Takahashi, N. Takasuka, M. Iigo, M. Baba, H. Nishino, H. Tsuda, and T. Okuyama Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development Cancer Sci. 95 2004 448 453 (Pubitemid 38832690)
7. Y.M. Lee, Y. Lim do, H.J. Choi, J.I. Jung, W.Y. Chung, and J.H. Park Induction of cell cycle arrest in prostate cancer cells by the dietary compound isoliquiritigenin J. Med. Food 12 2009 8 14
8. M. Tawata, K. Aida, T. Noguchi, Y. Ozaki, S. Kume, H. Sasaki, M. Chin, and T. Onaya Anti-platelet action of isoliquiritigenin, an aldose reductase inhibitor in licorice Eur. J. Pharmacol. 212 1992 87 92
9. S.M. Yu, and S.C. Kuo Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta Br. J. Pharmacol. 114 1995 1587 1594
10. H. Kakegawa, H. Matsumoto, and T. Satoh Inhibitory effects of some natural products on the activation of hyaluronidase and their anti-Allergic actions Chem. Pharm. Bull. 40 1992 1439 1442
11. S. Tamir, M. Eizenberg, D. Somjen, S. Izrael, and J. Vaya Estrogen-like activity of glabrene and other constituents isolated from licorice root J. Steroid. Biochem. Mol. Biol. 78 2001 291 298 (Pubitemid 32953624)
12. D.C. Kim, S.Y. Choi, S.H. Kim, B.S. Yun, I.D. Yoo, N.R. Reddy, N.R. Reddy, H.S. Yoon, and K.T. Kim Isoliquiritigenin selectively inhibits H2 histamine receptor signaling Mol. Pharmacol. 70 2006 493 500 (Pubitemid 44092310)
13. C. Zhan, and J. Yang Protective effects of isoliquiritigenin in transient middle cerebral artery occlusion-induced focal cerebral ischemia in rats Pharmacol. Res. 53 2006 303 309 (Pubitemid 43247544)
14. F. Lan, J.M. Cacicedo, N. Ruderman, and Y. Ido SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMPactivated protein kinase activation J. Biol. Chem. 283 2008 27628 27635
15. K.T. Howitz, K.J. Bitterman, H.Y. Cohen, D.W. Lamming, S. Lavu, J.G. Wood, R.E. Zipkin, P. Chung, A. Kisielewski, L.L. Zhang, B. Scherer, and D.A. Sinclair Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 425 2003 191 196 (Pubitemid 37150899)
16. Y. Luo, A.L. Eggler, D. Liu, G. Liu, A.D. Mesecar, and R.B. van Breemen Sites of alkylation of human Keap1 by natural chemoprevention agents J. Am Soc. Mass. Spectrom. 18 2007 2226 2232 (Pubitemid 350161332)
17. M. Kobayashi, L. Li, N. Iwamoto, Y. Nakajima-Takagi, H. Kaneko, Y. Nakayama, M. Eguchi, Y. Wada, Y. Kumagai, and M. Yamamoto The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds Mol. Cell. Biol. 29 2009 493 502
18. X.Y. Zhang, J.P. Liu, H. Qiao, J.M. Ni, and Y.B. Shi Determination and pharmacokinetics of Isoliquiritigenin in rat plasma by reverse phase high-performance liquid chromatography after intravenous administration Chromatographia 70 2009 423 430
19. X.Y. Zhang, H. Qiao, J.M. Ni, Y.B. Shi, and Y. Qiang Preparation of isoliquiritigenin-loaded nanostructured lipid carrier and the in vivo evaluation in tumor-bearing mice Eur. J. Pharm. Sci. 49 2013 411 422
20. H. Qiao, X.Y. Zhang, T. Wang, L. Liang, W. Chang, and H.X. Xia Pharmacokinetics, biodistribution and bioavailability of isoliquiritigenin after intravenous and oral administration Pharm. Biol. 52 2014 228 236
21. D.B. Fenske, and P.R. Cullis Liposomal nanomedicines Expert. Opin. Drug Deliv. 5 2008 25 44 (Pubitemid 351234108)
22. M. Rawat, D. Singh, and S. Saraf Lipid carrier: a versatile delivery vehicle for proteins and peptides Yakugaku. Zasshi. 128 2008 269 280 (Pubitemid 351237899)
23. I.P. Kaur, R. Bhandari, S. Bhandari, and V. Kakkar Potential of solid lipid nanoparticles in brain targeting J. Control. Release 127 2008 97 109
24. R.H. Müller, M. Radtke, and S.A. Wissing Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations Adv. Drug Deliv. Rev. 54 Suppl. 1 2002 S131 S155
25. E.B. Souto, and R.H. Müller Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes Handb. Exp. Pharmacol. 197 2010 115 141
26. X.H. Lin, X.W. Li, L.Q. Zheng, L. Yu, Q.Q. Zhang, and W.C. Liu Preparation and characterization of monocaprate nanostructured lipid carriers Colloids Surf. A Physicochem. Eng. Asp. 311 2007 106 111 (Pubitemid 350026290)
27. R.H. Müller, M. Radtke, and S.A. Wissing Nanostructured lipid matrices for improved microencapsulation of drugs Int. J. Pharm. 242 2002 121 128
28. R. Tiwari, and K. Pathak Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake Int. J. Pharm. 415 2011 232 243
29. S. Selvamuthukumar, and R. Velmurugan Nanostructured lipid carriers: a potential drug carrier for cancer chemotherapy Lipids Health Dis. 11 2012 159-159
30. M.A. Iqbal, S. Md, J.K. Sahni, S. Baboota, S. Dang, and J. Ali Nanostructured lipid carriers system: recent advances in drug delivery J. Drug Target. 20 2012 813 830
31. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 2000 271 284 (Pubitemid 30122932)
32. X.Y. Zhang, J.P. Liu, H. Qiao, H. Liu, J.M. Ni, W.L. Zhang, and Y.B. Shi Formulation optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology Powder Technol. 197 2010 120 128
33. T. Nook, E. Doelker, and P. Buri Intestinal absorption kinetics of various model drugs in relation to partition coefficients Int. J. Pharm. 43 1988 119 129 (Pubitemid 18097535)
34. L. Barthe, J. Woodley, and G. Houin Gastrointestinal absorption of drugs: methods and studies Fundam. Clin. Pharmcol. 13 1999 154 168 (Pubitemid 32324243)
35. X.N. Zhang, J. Chen, and Q. Zhang Study on the release of albendazole anoparticles in vitro and its correlation with uptake in stomach and intestinal absorption kinetics in rats Chin. Pharm. J. 38 12 2003 932 935 (Pubitemid 38297677)
36. C. Michel, M. Aprahamian, L. Defontaine, P. Couvreur, and C. Damgé The effect of site of administration in the gastrointestinal tract on the absorption of insulin from nanocapsules in diabetic rats J. Pharm. Pharmacol. 43 1991 1 5
37. H. Lv, G. Wang, X. Wu, L. Xie, C. Huang, H. Li, Y. Liang, H. Hao, and J. Sun Transport characteristics of ginkgolide B by Caco-2 cells and examination of ginkgolide B oral absorption potential using rat in situ intestinal loop method Int. J. Pharm. 351 2008 31 35 (Pubitemid 351186840)
38. N. Rouge, P. Buri, and E. Doelker Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery Int. J. Pharm. 136 1996 117-139; 36
39. Z.Q. Luo, Y. Liu, B.S. Zhao, M.M. Tang, H.H. Dong, L. Zhang, B.R. Lv, and L. Wei Ex vivo and in situ approaches used to study intestinal absorption J. Pharmacol. Toxicol. Methods 68 2013 208 216
40. R. Jain, S. Duvvuri, V. Kansara, N.K. Mandava, and A.K. Mitra Intestinal absorption of novel-dipeptide prodrugs of saquinavir in rats Int. J. Pharm. 336 2007 233 240 (Pubitemid 46670646)
41. Y. Gao, L. He, H. Katsumi, T. Sakane, T. Fujita, and A. Yamamoto Improvement of intestinal absorption of water-soluble macromolecules by various polyamines: intestinal mucosal toxicity and absorption-enhancing mechanism of spermine Int. J. Pharm. 354 2008 126 134
42. Y.M. Ma, and R.Y. Sun Second peak of plasma diazepam concentration and enterogastric circulation Acta Pharmacol. Sin. 14 1993 218 221
43. J. Xing, X. Chen, and D. Zhong Absorption and enterohepatic circulation of baicalin in rats Life Sci. 78 2005 140 146 (Pubitemid 41560966)
44. D.S. Meng, and Y.M. Hu Phenomena of double peaks in the tetrandrine concentration time curves Chin. J. Clin. Pharm. 8 1999 303 305
45. H.W. Zhou, J.Q. Shen, M. Lu, W.Q. Liang, W. Lin, and W.H. Zhao Pharmacokinetic analysis of enterohepatic circulation of piroxicam in rabbits Zhongguo Yao Li Xue Bao 13 1992 180 182
46. R.L. Oberle, and G.L. Amidon The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine: an explanation for the double peak phenomenon J. Pharm. Biopharm. 15 1987 529 544
47. N. Hussain, V. Jaitley, and A.T. Florence Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics Adv. Drug Deliv. Rev. 50 2001 107 142 (Pubitemid 32727279)
48. H. Yuan, J. Chen, Y.Z. Du, F.Q. Hu, S. Zeng, and H.L. Zhao Studies on oral absorption of stearic acid SLN by a novel fluorometric method Colloids Surf. B Biointerfaces 58 2007 157 164 (Pubitemid 46921452)
49. K. Manjunath, and V. Venkateswarlu Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration J. Control. Release 107 2005 215 228 (Pubitemid 41319672)
50. D. Duchêne, and G. Ponchel Bioadhesion of solid oral dosage forms, why and how? Eur. J. Pharm. Biopharm. 44 1997 15 23 (Pubitemid 28298771)
51. N. Venkatesan, K. Uchino, K. Amagase, Y. Ito, N. Shibata, and K. Takada Gastrointestinal patch system for the delivery of erythropoietin J. Control. Release 111 2006 19 26 (Pubitemid 43289990)
52. S.J. Lim, M.K. Lee, and C.K. Kim Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders J. Control. Release 100 2004 53 61
53. N.L. Trevaskis, W.N. Charman, and C.J.H. Porter Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update Adv. Drug Deliv. Rev. 60 2008 702 716
54. J.K. Vasir, K. Tambwekar, and S. Garg Bioadhesive microspheres as a controlled drug delivery system Int. J. Pharm. 255 2003 13 32 (Pubitemid 36369587)